Vima LLC’s CRISPR Therapeutics CRSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-518
Closed -$23.4K 126
2024
Q1
$23.4K Buy
518
+326
+170% +$14.7K 0.03% 173
2023
Q4
$12K Buy
+192
New +$12K 0.03% 234